• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Zebra Body Formation Due to Drug-Induced Phospholipidosis Observed on Electron Micrographs.

作者信息

Kawahara Hiroshi, Endo Akihiro, Yoshitomi Hiroyuki, Tanabe Kazuaki

机构信息

Division of Cardiology, Shimane University Faculty of Medicine Izumo Japan.

Clinical Laboratory Division, Shimane University Faculty of Medicine Izumo Japan.

出版信息

Circ Rep. 2021 Jan 13;3(2):110-111. doi: 10.1253/circrep.CR-20-0129.

DOI:10.1253/circrep.CR-20-0129
PMID:33693298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7939952/
Abstract
摘要

相似文献

1
Zebra Body Formation Due to Drug-Induced Phospholipidosis Observed on Electron Micrographs.电子显微镜下观察到药物诱导的磷脂沉积症导致的斑马小体形成。
Circ Rep. 2021 Jan 13;3(2):110-111. doi: 10.1253/circrep.CR-20-0129.
2
Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease.羟氯喹诱导的肾磷脂沉积症中类似法布里病的曲线形小体。
Clin Kidney J. 2013 Oct;6(5):533-6. doi: 10.1093/ckj/sft089. Epub 2013 Aug 13.
3
High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.高内涵筛选分析磷脂蓄积症：CHO-K1 和 HepG2 细胞 96 孔板检测法的验证，用于预测基于体内的磷脂蓄积症。
Toxicol In Vitro. 2011 Dec;25(8):1870-82. doi: 10.1016/j.tiv.2011.05.026. Epub 2011 May 30.
4
Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report.羟氯喹诱导的肾磷脂沉积症在未分化结缔组织病中类似法布里病：一例报告
World J Clin Cases. 2019 Dec 26;7(24):4377-4383. doi: 10.12998/wjcc.v7.i24.4377.
5
In vitro assays and biomarkers for drug-induced phospholipidosis.药物诱导的磷脂沉积症的体外检测方法和生物标志物
Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):687-96. doi: 10.1517/17425255.2.5.687.
6
A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.一种用于药物诱导的磷脂沉积症的毒理基因组学方法：其诱导机制分析及新型体外筛选系统的建立。
Toxicol Sci. 2005 Feb;83(2):282-92. doi: 10.1093/toxsci/kfh264. Epub 2004 Sep 1.
7
Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice.酮康唑处理小鼠肝脏和肾脏中磷脂沉积症的LAMP-2和脂肪分化相关蛋白免疫组织化学研究
Exp Toxicol Pathol. 2013 Sep;65(6):817-23. doi: 10.1016/j.etp.2012.11.008. Epub 2012 Dec 28.
8
Renal phospholipidosis possibly induced by ranolazine.雷诺嗪可能诱发的肾磷脂沉积症。
Clin Kidney J. 2014 Feb;7(1):62-4. doi: 10.1093/ckj/sft141. Epub 2013 Dec 10.
9
Phospholipidosis effect of drugs by adsorption into lipid monolayers.药物通过吸附进入脂质单层的磷脂沉积效应。
Colloids Surf B Biointerfaces. 2015 Dec 1;136:175-84. doi: 10.1016/j.colsurfb.2015.09.003. Epub 2015 Sep 5.
10
Silymarin and vitamin E reduce amiodarone-induced lysosomal phospholipidosis in rats.水飞蓟素和维生素E可减轻胺碘酮诱导的大鼠溶酶体磷脂沉积症。
Toxicology. 2003 Aug 28;190(3):231-41. doi: 10.1016/s0300-483x(03)00188-4.

引用本文的文献

1
Critical heart failure associated with beta-blocker-induced cardiac phospholipidosis: a case report.与β受体阻滞剂诱导的心脏磷脂沉积症相关的严重心力衰竭：一例报告
Eur Heart J Case Rep. 2024 Nov 14;8(12):ytae608. doi: 10.1093/ehjcr/ytae608. eCollection 2024 Dec.
2
Zebra Body Not Caused by Fabry Disease.
Intern Med. 2023 Nov 15;62(22):3425-3426. doi: 10.2169/internalmedicine.1558-23. Epub 2023 Mar 31.

本文引用的文献

1
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis　- Digest Version.《日本循环学会2016年心脏结节病诊断与治疗指南 - 摘要版》
Circ J. 2019 Oct 25;83(11):2329-2388. doi: 10.1253/circj.CJ-19-0508. Epub 2019 Oct 9.
2
Identification of drugs inducing phospholipidosis by novel in vitro data.新型体外数据鉴定致磷脂沉积病药物。
ChemMedChem. 2012 Nov;7(11):1925-34. doi: 10.1002/cmdc.201200306. Epub 2012 Sep 3.